Meeting
2020 Genitourinary Cancers Symposium
Characterization of Wnt signaling pathway (WSP) aberrations in advanced prostate cancer.
Authors
Fady Ghali
UC San Diego, Department of Urology, San Diego, CA
Fady Ghali , Devin Patel , Christina Jamieson , J Kellogg Parsons , Rana R. McKay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 203)
Abstract #
203
Poster Bd #
J17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC).
First Author: Amanda Broderick
Poster
2019 ASCO Annual Meeting
WNT activating pathway mutations confer resistance to first-line antiandrogen therapy in castration-resistant prostate cancer (CRPC).
First Author: Pedro Isaacsson Velho
Poster
2014 Genitourinary Cancers Symposium
Molecular profiling of advanced refractory prostate cancer.
First Author: Rebecca A. Feldman
Poster
2024 ASCO Genitourinary Cancers Symposium
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer.
First Author: Sharon Choi